Delivery Order SPE2DB22D1202-SPE2DB24FUSS9
Award Date 3/6/24
Potential Completion Date 3/7/24
Potential Value $2.8K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of XYOSTED 75 MG/0.5 ML AUTO-INJ 0.5ML pharmaceutical products. The total potential value of the delivery order is $1,452.66, with a completion date of March 7, 2024. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp, headquartered in Conshohocken, Pennsylvania,...
- The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor, to provide XYOSTED 75 MG/0.5 ML AUTO-INJ 0.5ML medication. The $1,060.98 contract has a completion date of May 14, 2024. Amerisourcebergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract with DLA Troop Support Medical to deliver a comprehensive range of pharmaceutical products and medical supplies...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of XYOSTED 75 MG/0.5 ML AUTO-INJ 0.5ML pharmaceutical products. The potential value of this contract is $3,817.38, with a period of performance through February 9, 2024. Amerisourcebergen Drug Corp, as a prime contractor, provides a wide range of pharmaceutical and medical supplies to U.S. government agencies,...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of XYOSTED 75 MG/0.5 ML AUTO-INJ 0.5ML. The $2,340.71 contract has an ultimate completion date of April 30, 2025 and does not utilize a set-aside. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which provides a comprehensive global...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $3,748.66 to Amerisourcebergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a global pharmaceutical distribution company. The contract is for the supply of XYOSTED 75 MG/0.5 ML AUTO-INJ 0.5ML, a specialty pharmaceutical product, with a completion date of February 6, 2024. This delivery order is issued under an Indefinite Delivery Contract (IDC) awarded to Amerisourcebergen Drug Corp by DLA,...
- The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order contract worth $1,252.44 to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor. The contract is for the delivery of XYOSTED 75 MG/0.5 ML AUTO-INJ 0.5ML, a medication. This order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with DLA Troop Support Medical, which serves as the primary vehicle for the company to supply a wide...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,381.75, is for the supply of XYOSTED 75 MG/0.5 ML AUTO-INJ 0.5ML, a pharmaceutical product. The contract is a firm fixed-price delivery order with a performance period ending on May 2, 2025. AmerisourceBergen Drug Corp is the prime contractor, and there is no indication of any major...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the pharmaceutical product XYOSTED 50 MG/0.5 ML AUTO-INJ 0.5ML. The contract has a potential value of $1,575.18 and a completion date of February 22, 2024. Amerisourcebergen Drug Corp, a for-profit organization, serves as the prime contractor providing pharmaceutical products and medical supplies to U.S. government agencies,...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of XYOSTED 100 MG/0.5 ML AUTO-INJ 0.5ML medication. The $1,175.27 firm fixed price contract has an ultimate completion date of October 30, 2024. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
- The U.S. government's Defense Logistics Agency (DLA) awarded a $2,920.13 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of XYOSTED 100 MG/0.5 ML AUTO-INJ 0.5ML pharmaceutical products. This contract has an ultimate completion date of April 18, 2024. Amerisourcebergen is a major supplier of pharmaceutical and medical products to the federal government, particularly to the Department of Defense (DoD) and...